{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:53:53Z","timestamp":1790970833327,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Youth Science and Technology Innovation Talent Cultivation Program of FJTCM","award":["XQC2024004"],"award-info":[{"award-number":["XQC2024004"]}]},{"name":"School Management Project of Fujian University of Chinese Traditional Medicine","award":["X2025004"],"award-info":[{"award-number":["X2025004"]}]},{"name":"Joint Funds for Science and Technology Innovation of Fujian Province","award":["2025Y9716"],"award-info":[{"award-number":["2025Y9716"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,2]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>\n                      Primary pulmonary lymphoma (PPL) is an extremely rare malignant lung tumor that is frequently misdiagnosed as pneumonia or lung cancer due to its atypical radiological and clinical presentation. The rationale of this report is to elucidate the diagnostic value of combining computed tomography (CT) and\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose positron emission tomography\/computed tomography (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT) in evaluating a rare presentation of PPL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 44-year-old male was admitted after an incidental lung lesion was discovered during routine screening. He was completely asymptomatic, lacking respiratory or systemic \u201cB symptoms.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      A baseline chest CT identified a 3.9\u2005\u00d7\u20053.5\u2009cm soft-tissue mass in the right hilar region that compressed the right upper lobe bronchus, leading to secondary post-obstructive consolidation that lacked the characteristic air bronchogram sign. The CT also revealed an incidental 2.6\u2005\u00d7\u20052.6\u2009cm anterior mediastinal nodule. Subsequent whole-body\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT demonstrated intense tracer uptake in the right hilar mass with a maximum standardized uptake value of 7.1 and mild-to-moderate uptake in an adjacent regional lymph node (maximum standardized uptake value of 3.2). The scan showed completely absent uptake in the anterior mediastinal nodule and the post-obstructive consolidation, arguing against metabolically active malignancy in those areas. Histopathological and immunohistochemical analysis from a bronchoscopic transbronchial lung biopsy confirmed primary pulmonary mucosa-associated lymphoid tissue lymphoma.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient underwent localized radiotherapy targeting the right hilar mass and the FDG-avid regional hilar\/posterior mediastinal lymph node. A total dose of 66 Gy was delivered in 18 fractions over the course of 3 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>At the 2-month post-discharge follow-up, a repeat chest CT revealed a marked reduction in the size of both the hilar lesion and the regional lymph nodes. The patient remained completely asymptomatic, and his laboratory parameters normalized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>\n                      Differentiating PPL from central lung cancer and coexisting benign mediastinal abnormalities presents a significant clinical challenge, particularly when atypical radiological features mimic aggressive carcinomas. Whole-body\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT serves as an invaluable, noninvasive modality for metabolic characterization, accurate loco-regional staging, and preventing clinical overstaging by effectively differentiating metabolically active lymphoma from concurrent benign lesions.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000051002","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:00:58Z","timestamp":1790967658000},"page":"e51002","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Primary pulmonary mucosa-associated lymphoid tissue lymphoma presenting as a right hilar mass"],"prefix":"10.1097","volume":"105","author":[{"given":"Liyuan","family":"Fu","sequence":"first","affiliation":[{"name":"Fuzong Teaching Hospital, Fujian University of Traditional Chinese Medicine (900th Hospital), Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6161-9098","authenticated-orcid":false,"given":"Taipeng","family":"Zeng","sequence":"additional","affiliation":[{"name":"Fuzong Teaching Hospital, Fujian University of Traditional Chinese Medicine (900th Hospital), Fuzhou, China"},{"name":"College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengkun","family":"Hong","sequence":"additional","affiliation":[{"name":"Fuzong Teaching Hospital, Fujian University of Traditional Chinese Medicine (900th Hospital), Fuzhou, China"},{"name":"College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Fuzong Teaching Hospital, Fujian University of Traditional Chinese Medicine (900th Hospital), Fuzhou, China"},{"name":"College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1007\/s00259-022-05872-z","article-title":"The role of 18F-FDG PET\/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma.","volume":"49","author":"Wang","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R2-20261002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.annpat.2015.11.007","article-title":"Carcinomes sarcomato\u00efdes pulmonaires [Pulmonary sarcomatoid carcinoma].","volume":"36","author":"Antoine","year":"2016","journal-title":"Ann Pathol"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1477-7819-10-131","article-title":"Primary lung lymphoma involving the superior vena cava.","volume":"10","author":"Wei","year":"2012","journal-title":"World J Surg Oncol"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/PAP.0000000000000090","article-title":"Primary pulmonary lymphomas.","volume":"22","author":"Pi\u00f1a-Oviedo","year":"2015","journal-title":"Adv Anat Pathol"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lungcan.2019.04.004","article-title":"Clinical features and outcomes of pulmonary lymphoma: a single center experience of 180 cases.","volume":"132","author":"Zhang","year":"2019","journal-title":"Lung Cancer"},{"key":"R6-20261002","first-page":"66","article-title":"Peribronchial lymphosarcoma with rapid intrapulmonary development.","volume":"23","author":"Pekelis","year":"1931","journal-title":"Pathologica"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.21037\/tcr.2020.02.16","article-title":"A retrospective study on the clinical characteristics and radiological features of primary pulmonary lymphoma.","volume":"9","author":"Xie","year":"2020","journal-title":"Transl Cancer Res"},{"key":"R8-20261002","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1749-8090-6-23","article-title":"Forty years literature review of primary lung lymphoma.","volume":"6","author":"Parissis","year":"2011","journal-title":"J Cardiothorac Surg"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"973109","DOI":"10.3389\/fonc.2022.973109","article-title":"Role of 18F-FDG PET\/CT in patients affected by pulmonary primary lymphoma.","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s13277-012-0474-4","article-title":"Effects of microvascular density on primary pulmonary non-Hodgkin\u2019s lymphoma (PPL).","volume":"33","author":"Yang","year":"2012","journal-title":"Tumour Biol"},{"key":"R11-20261002","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s003300000491","article-title":"Pulmonary MALT lymphoma: imaging findings in 24 cases.","volume":"10","author":"King","year":"2000","journal-title":"Eur Radiol"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0972-3919.181529","article-title":"Primary pulmonary lymphoma-role of fluoro-deoxy-glucose positron emission tomography-computed tomography in the initial staging and evaluating response to treatment \u2013 case reports and review of literature.","volume":"31","author":"Agarwal","year":"2016","journal-title":"Indian J Nucl Med"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/10428194.2016.1225210","article-title":"Primary pulmonary lymphoma: four different and unusual radiologic and clinical manifestations.","volume":"58","author":"Tanriverdi","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"15330338221075529","DOI":"10.1177\/15330338221075529","article-title":"Clinical analysis of 50 cases of primary pulmonary lymphoma: a retrospective study and literature review.","volume":"21","author":"Hu","year":"2022","journal-title":"Technol Cancer Res Treat"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1378\/chest.07-1956","article-title":"Marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue: imaging findings in 21 patients.","volume":"133","author":"Bae","year":"2008","journal-title":"Chest"},{"key":"R16-20261002","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.seminoncol.2019.07.001","article-title":"PET\/CT in radiation oncology.","volume":"46","author":"Fonti","year":"2019","journal-title":"Semin Oncol"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11307-018-1181-3","article-title":"The evolving role of FDG-PET\/CT in the diagnosis, staging, and treatment of breast cancer.","volume":"21","author":"Paydary","year":"2019","journal-title":"Mol Imaging Biol"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hon.2152","article-title":"Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis.","volume":"33","author":"Treglia","year":"2015","journal-title":"Hematol Oncol"},{"key":"R19-20261002","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.21037\/jtd.2018.10.63","article-title":"HRCT in primary pulmonary lymphoma: can CT imaging phenotypes differentiate histological subtypes between mucosa-associated lymphoid tissue (MALT) lymphoma and non-MALT lymphoma?","volume":"10","author":"Chen","year":"2018","journal-title":"J Thorac Dis"},{"key":"R20-20261002","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1097\/CM9.0000000000000378","article-title":"An 11 years delayed diagnosis of primary pulmonary diffuse large B cell lymphoma.","volume":"132","author":"Yu","year":"2019","journal-title":"Chin Med J (Engl)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:01:01Z","timestamp":1790967661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051002"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":20,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000051002","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"2025-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}